Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yogin Patel

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
American Heart Journal|September 26, 2006
The impact of emergency department structure and care processes in delivering care for non-ST-segment elevation acute coronary syndromesRajendra H Mehta, L Kristin Newby, Yogin Patel, et al.
JAMA Oncology|September 1, 2017
Salvage Chemoimmunotherapy With Inotuzumab Ozogamicin Combined With Mini-Hyper-CVD for Patients With Relapsed or Refractory Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: A Phase 2 Clinical TrialElias Jabbour, Farhad Ravandi, Partow Kebriaei, et al.
Cell Reports|August 4, 2022
Cancer genes disfavoring T cell immunity identified via integrated systems approachRigel J Kishton, Shashank J Patel, Amy E Decker, et al.
Med (New York, N.Y.)|August 25, 2022
Internal checkpoint regulates T cell neoantigen reactivity and susceptibility to PD1 blockadeDouglas C Palmer, Beau R Webber, Yogin Patel, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
American Heart Journal|September 26, 2006
The impact of emergency department structure and care processes in delivering care for non-ST-segment elevation acute coronary syndromesRajendra H Mehta, L Kristin Newby, Yogin Patel, et al.
JAMA Oncology|September 1, 2017
Salvage Chemoimmunotherapy With Inotuzumab Ozogamicin Combined With Mini-Hyper-CVD for Patients With Relapsed or Refractory Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: A Phase 2 Clinical TrialElias Jabbour, Farhad Ravandi, Partow Kebriaei, et al.
Cell Reports|August 4, 2022
Cancer genes disfavoring T cell immunity identified via integrated systems approachRigel J Kishton, Shashank J Patel, Amy E Decker, et al.
Med (New York, N.Y.)|August 25, 2022
Internal checkpoint regulates T cell neoantigen reactivity and susceptibility to PD1 blockadeDouglas C Palmer, Beau R Webber, Yogin Patel, et al.
Pageof 3